In veterinary medicine, treating cells with IGF-1 was shown to increase invasiveness in just one of three osteosarcoma cell lines (with high insulin-like growth factor receptor 1 (IGF1-R) expression) [42]. This evidence concerns the gene IGF1R and osteosarcoma.